Humana Soars 16% on Improved Medicare Advantage Star Ratings; CVS Slides 3%, UnitedHealth Holds Steady

Impact · against what's priced in

Humana's improved Star Ratings act as a significant catalyst by validating the recovery the market had previously declined to price in. For CVS, the ratings release serves as a negative signal that reinforces the market's existing reluctance to credit the company with further margin expansion.

HUM+0.70: Challenges what's priced in
The price assumes: A full recovery to top-quartile Star Ratings for bonus year 2028

Humana Soars 16% on Improved Medicare Advantage Star Ratings; CVS Slides 3%, UnitedHealth Holds Steady

What matters in this story

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now

Humana Soars 16% on Improved Medicare Advantage Star Ratings; CVS Slides 3%, UnitedHealth Holds Steady

What matters in this story

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now

How each ticker is affected

Connected tickers

Track these names every morning.

Do Options Traders Know Something About Harrow Stock We Don't?

Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength?

Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength?

Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care

Humana Soars 16% on Improved Medicare Advantage Star Ratings; CVS Slides 3%, UnitedHealth Holds Steady

What matters in this story

Next reads from the same story arc

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now

Humana Soars 16% on Improved Medicare Advantage Star Ratings; CVS Slides 3%, UnitedHealth Holds Steady

What matters in this story

Next reads from the same story arc

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now

How each ticker is affected

Connected tickers

Track these names every morning.

Do Options Traders Know Something About Harrow Stock We Don't?

Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength?

Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength?

Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care